GlassScriptPhysician profile
Wendy N May
NPI 1326021981
$5,305.89
in general payments reported to CMS, 2019-2025
39 companies · $415 in 2025
The $415 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $624 · 2020: $771 · 2021: $868 · 2022: $594 · 2023: $958 · 2024: $1,076 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,448.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $672.48 | 2020-2025 | |
| Novo Nordisk INC | $653.99 | 2019-2025 | Ozempic, Wegovy, Saxenda |
| Lilly USA, LLC | $576.29 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $491.69 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $410.31 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $390.09 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $242.18 | 2020-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $189.33 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $129.25 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $124.77 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $112.09 | 2021-2022 | |
| Amarin Pharma, INC. | $107.68 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $107.25 | 2022 | |
| Abbott Laboratories | $102.35 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Sanofi-Aventis U.S. LLC | $98.92 | 2020-2023 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.